Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213544 · ClinicalTrials.gov registry record · Phase 4
Remimazolam vs Propofol in Laser Burn Cases
A Phase 4 study of Burn Scar and Procedural Sedation, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
- 1
- Study location
NCT07213544 is a Phase 4 study of Burn Scar and Procedural Sedation that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 136 participants, above the 36-participant average among 4 other Burn Scar trials with a reported enrollment target (278% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07213544, a Phase 4 study of Burn Scar and Procedural Sedation, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, single-blind, crossover study compares remimazolam and propofol for monitored anesthetic care during fractional ablative CO₂ laser therapy for burn scars. The primary aim is to assess incidence of respiratory depression, defined as a need for advanced airway maneuvers (jaw thrust/chin lift, insertion of oral or nasal airway, or bag mask ventilation), and hypopnea (respiratory rate \< 8).
Conditions Studied
Interventions
- DRUG Propofol
- DRUG Remimazolam besylate
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213544
The ClinicalTrials.gov registry entry for NCT07213544 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 36-participant average among 4 other Burn Scar trials with a reported enrollment target (278% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Burn Scar appearing as the primary indexed condition, and to 2 interventions - of which Propofol is the first listed.
NCT07213544 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT07213544 about?
NCT07213544 is a clinical study titled "Remimazolam vs Propofol in Laser Burn Cases". This randomized, single-blind, crossover study compares remimazolam and propofol for monitored anesthetic care during fractional ablative CO₂ laser therapy for burn scars. The primary aim is to assess incidence of respiratory depression, defined as a need for advanced airway maneuvers (jaw thrust/ch...
What is the current status of trial NCT07213544?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2025-11-12. Estimated completion is 2027-01-01.
What conditions does trial NCT07213544 study?
This clinical trial studies the following conditions: Burn Scar, Procedural Sedation, Hypertrophic Scarring.
What interventions are being tested in trial NCT07213544?
The interventions under investigation include: Propofol (DRUG), Remimazolam besylate (DRUG).
Who is sponsoring clinical trial NCT07213544?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213544 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burn Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.